Domino.ai (Real-World Evidence Platform)

by Domino Data Lab  · Based in United States → — The Enterprise AI Platform to build, scale, and govern AI-powered applications.
Cardiology Internal Medicine Oncology
Website
Claim this tool
Is this the maker? Claim the company →

Subscription

Overview

Domino.ai, powered by Domino Data Lab’s Enterprise AI Platform, is designed to accelerate insights, improve consistency, and ensure traceability from data to decision in real-world evidence generation. The platform provides an integrated experience encompassing model development, MLOps, collaboration, and governance. It enables global enterprises to develop better medicines, grow more productive crops, develop more competitive products, and more. Domino’s platform is an open system that unifies various programming languages, integrated development environments (IDEs), data sources, and tools in one location, providing self-service access to data and tools, enabling reuse of materials, and facilitating collaboration while enforcing best practices and enhancing knowledge and efficiency.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Model Development, MLOps, Collaboration, and Governance
  • Unified, Collaborative, Governed, and End-to-End AI
  • Audit-ready platform with reproducibility, model governance, monitoring, and remediation
  • Cost optimization with proactive FinOps, intelligent Spot Instance usage, and autoscaling
  • Self-service access to IDEs, secure connections to enterprise datasets, and elastic compute
  • Continuous monitoring of models and data for compliance checks
  • Data sovereignty support for regional access restrictions and local data processing
  • Supports any programming language or IDE, open-source and commercial tooling
  • Connects to external data sources like databases, data warehouses, and data lakes
  • Hybrid and multi-cloud deployment options

Use Cases

  • Accelerating real-world evidence generation in life sciences
  • Developing better medicines and advancing drug discovery
  • Managing AI risks and ensuring compliance with frameworks like NIST AI RMF
  • Optimizing costs and resource utilization for AI workloads
  • Enabling self-service data science for increased productivity
  • Building and deploying AI-powered applications across various industries

What Physicians Need to Know

Real-World Evidence Analysis
Domino.ai's platform is designed to bring together diverse real-world datasets and predictive models to generate regulatory-grade evidence. It simplifies data access, scales complex analyses, and ensures full traceability for real-world evidence (RWE) across clinical development, HEOR, and medical affairs. The platform enables the training, deployment, and reuse of predictive models to forecast outcomes and drive decisions, and allows exploration of patient journeys and cohorts through interactive dashboards. It supports the use of real-world data (RWD) for safety signal detection and risk management in both pre- and post-market settings.
Clinical Trial Matching
Domino.ai's platform is trusted by life sciences companies to identify clinical trial subjects. It can leverage large language models (LLMs) to mine electronic health records (EHR) to identify eligible patients and predict early signs of dropout or adverse events, and analyze prior trial designs to optimize new ones. The platform supports AI-powered solutions for automating patient-to-trial matching by processing heterogeneous clinical data, including structured records and unstructured physician notes.
Genomic Data Integration
The platform can track and trace genomic data aggregated from thousands of tumor samples, enabling researchers to test numerous hypotheses with complete reproducibility. It allows for the cataloging and understanding of various data sources, including molecular-based data. Domino.ai helps analyze data from over 10,000 tumors to uncover connections, leading to discoveries such as new classes of drugs and insights into immune system responses to cancer cells.
Literature Mining
Large language models (LLMs) on the Domino.ai platform can help researchers synthesize findings from thousands of publications and speed up literature reviews. It also utilizes BioRAG (Retrieval Augmented Generation) to retrieve and summarize relevant information from vast clinical datasets in real-time, providing accurate and concise summaries of complex clinical documents. AI identifies drug targets by mining multi-omics data, genetic association evidence, and knowledge graphs to prioritize genes.
Target Identification
AI-driven models on the Domino.ai platform can accelerate drug discovery by identifying potential drug candidates and predicting their efficacy. It supports AI-powered inverse design to define target material properties and identify matching compositions, reducing the need for extensive experimentation. AI identifies drug targets by mining multi-omics data, genetic association evidence, and knowledge graphs. The platform has been instrumental in identifying new classes of drugs and understanding their impact on individuals.
Safety Signal Detection
The platform supports the use of real-world data (RWD) to detect, evaluate, and manage safety signals in both pre- and post-market settings. AI in pharmacovigilance can enhance processes like data analysis and signal detection by increasing efficiency and accuracy, and managing large datasets.
Collaboration Features
Domino.ai provides an open, unified, and collaborative platform that gives teams the flexibility to use modern tools, data, and technologies. It acts as a central hub for AI operations and knowledge, enabling best practices, cross-functional collaboration, and faster innovation. The platform fosters a culture of collaboration by eliminating silos between data scientists and business teams. It also supports the reuse of past models and project artifacts, accelerating delivery.
Publication Support
The platform ensures reproducibility and compliance with built-in versioning, audit trails, and access controls, which are essential for generating regulatory-grade evidence. Researchers and data scientists can submit research to the FDA from the same platform they use for R&D, eliminating the need to rewrite code on a different platform. It provides end-to-end traceability and reproducibility for regulatory compliance, accelerating cycle times for regulatory submissions.
Physician Tip

Physicians can leverage Domino.ai's Real-World Evidence Platform to access interactive dashboards for exploring patient journeys and cohorts, gaining insights from diverse real-world datasets. The platform's capabilities in clinical trial matching, especially with LLM-powered EHR mining, can help identify eligible patients more efficiently. Furthermore, the genomic data integration and target identification features can provide deeper insights into disease mechanisms and potential treatment pathways, aiding in personalized medicine approaches. The platform's focus on reproducibility and audit trails ensures that the evidence generated is reliable and compliant with regulatory standards, supporting informed clinical decision-making.

Domino.ai is an open system that provides self-service access to various data and tools. It connects to external data sources like databases, data warehouses, and data lakes. The platform allows data scientists to use preferred languages and tools such as Python, SAS, Matlab, and R, and integrates with IDEs like Jupyter Notebook, JupyterLab, RStudio, and VS Code. It also supports integration with software like Jira, GitHub, MLflow, and Sagemaker for seamless data science workflows. Domino.ai can deploy LLMs to Amazon SageMaker and access large language models via Amazon Bedrock, backed by Domino's governance capabilities. The platform also has an extensions framework that allows customers and partners to embed their own tools and workflows directly into the Domino interface, such as Appsilon's Axon.R extension for validating R packages for life sciences. It integrates with infrastructure like Azure Kubernetes, Azure Data Lake Storage, Shiny Dashboards, Databricks, and Azure SQL.

Details

Category Drug Discovery & Research, Population Health Analytics
Pricing Subscription
  • Custom quotes based on users, computational resources, and support levels; Pricing tiers vary by features, scale, and deployment options; Domino Cloud (fully managed SaaS) with per-user licensing plus monthly consumption units; Self-managed VPC Premium fee for platforms run in customer's own environment
DeploymentCloud (SaaS), On-premises, Hybrid, Multi-cloud
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

Domino supports customer compliance with frameworks such as 21 CFR Part 11 and EudraLex Annex 11, and delivers the traceability and governance required for GxP processes.
Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Oncology

What the Web Says

Domino.ai's Real-World Evidence Platform is designed to help life sciences teams accelerate real-world evidence generation across clinical development, HEOR, and medical affairs. The platform aims to bring together diverse real-world datasets, predictive models, and compliant workflows to deliver reusable, interactive insights in a single environment. It emphasizes simplifying data access, scaling complex analyses, and ensuring full traceability for regulatory-grade evidence.

Overall: Positive

Strengths

  • User-friendly interface and ease of use in training and deploying models.
  • Seamless integration with various cloud services (e.g., AWS, Azure), streamlining the AI lifecycle.
  • Facilitates collaboration between data scientists, engineers, and other stakeholders, allowing easy sharing of code, data, and results.
  • Robust and scalable platform that can handle large-scale real-world data from multiple sources.
  • Built-in versioning, audit trails, and access controls ensure reproducibility and compliance.
  • Accelerates time to production at scale with MLOps integration.

Limitations

  • Steep learning curve for beginners and new users, especially for understanding implementation steps for deploying and monitoring models.
  • Complex implementation process for larger companies.
  • Integration with third-party applications may require additional customizations.
  • Customer support and training documents could be improved.
  • Security concerns have been raised, with new features sometimes causing security or compliance problems.
  • Difficult to automate deployment, and critical parts of the application are not available via a documented API.

Based on reviews from: G2, Domino Data Lab (Official Website), Gartner Peer Insights, Capterra, Reddit, AWS Marketplace

Last updated: 2026-08-23

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Domino.ai (Real-World Evidence Platform)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Domino Data Lab (via PR Newswire)
Domino Unveils New Capabilities to Take AI From Model to Mission-Critical Application
Domino Data Lab announced new capabilities for its Enterprise AI Platform at its annual Rev conference, enabling regulated enterprises to build, scale, and govern AI-powered applications across the full application lifecycle. These new features are designed to help organizations move AI from research projects to mission-critical business operations, particularly in regulated environments like life sciences.
2026-05
Domino Data Lab
New Domino Capabilities and Momentum Fuel Life Sciences Innovation
Domino Data Lab announced new capabilities and significant traction in the life sciences industry, with six of the top 10 pharmaceutical companies now utilizing their platform for AI and analytics. The updates include Domino Apps for interactive insights and enhanced support for 21 CFR Part 11 compliance, aiming to accelerate drug discovery and development.
2025-05
Domino Data Lab
21 CFR Part 11: Meeting FDA compliance requirements - Domino Data Lab
This article highlights how the Domino Enterprise AI Platform helps life sciences teams meet FDA 21 CFR Part 11 compliance requirements for computational sciences and AI/ML, addressing challenges like fragmented documentation and reproducibility. It emphasizes the platform's built-in controls to maintain compliance without hindering research.
2025-06
Domino Data Lab
Domino Empowers Enterprise IT to Scale AI ROI for Maximum Impact, Lower Cost
Domino Data Lab announced updates to Domino Cloud designed to help enterprise IT teams scale AI value, maximize impact, and reduce infrastructure costs. New capabilities include spot instance support for cost reduction and managed data planes for physically isolated data, addressing challenges in achieving AI ROI.
2025-10
unknown
How AI-Enabled Real-World Evidence Solutions are Impacting Pharma's Value Chain
This article discusses how AI is transforming Real-World Evidence (RWE) solutions, enabling pharma to automate data harmonization and derive insights from diverse Real-World Data (RWD) sources across the drug value chain. It highlights AI's role in accelerating discovery, enhancing clinical trial design, and improving post-market surveillance.
2025-11
PMC (PubMed Central)
Towards responsible artificial intelligence in healthcareu2014getting real about real-world data and evidence - PMC
This paper identifies challenges and proposes guidelines for the responsible use of Real-World Data (RWD) and Real-World Evidence (RWE) in healthcare AI, addressing issues like interpretability, bias, privacy, and accountability. It emphasizes the need for robust assurance and privacy standards to ensure safe, effective, equitable, and trustworthy AI innovations.
2025-09
YouTube (Domino Data Lab)
AI & Data Analytics Platform for Life Sciences
This video highlights how leading life sciences companies leverage Domino's AI and data analytics platform to identify clinical trial subjects, advance real-world evidence, and accelerate drug discovery. The platform ensures compliant R&D pipelines and reproducibility with its open, unified, and collaborative environment.
2026-03
PR Newswire
Domino Data Lab Joins U.S. Department of Energy's Genesis Mission Consortium to Accelerate AI-Driven Scientific Discovery
Domino Data Lab has joined the U.S. Department of Energy's Genesis Mission Consortium, aiming to apply its platform's capabilities in rapid scientific insight, governance, reproducibility, and auditability to national laboratories. This collaboration seeks to double the productivity and impact of America's science and engineering through AI-driven discovery.
2026-08

Videos

Product demos, reviews, and walkthroughs for Domino.ai (Real-World Evidence Platform).

View all on YouTube

Frequently Asked Questions

Domino.ai utilizes a variety of Real-World Evidence (RWE), including electronic health records (EHRs), claims data, patient registries, and genomic data, to provide insights into disease progression, treatment effectiveness, and patient outcomes. This data is analyzed to identify potential drug targets, stratify patient populations for clinical trials, and generate hypotheses for new therapeutic approaches, ultimately aiming to accelerate the drug discovery process.
Domino.ai adheres to strict compliance and data privacy regulations, including HIPAA and GDPR, through robust de-identification and anonymization techniques for all patient data. The platform employs secure data enclaves and access controls, ensuring that researchers only interact with aggregated and anonymized insights rather than individual patient records, thereby safeguarding patient confidentiality.
Domino.ai employs a multi-faceted approach to ensure RWE quality and reliability, including data standardization, curation, and validation processes. This involves working with trusted data partners, implementing rigorous data governance frameworks, and utilizing machine learning algorithms to identify and correct inconsistencies or biases within the datasets, thereby enhancing the trustworthiness of the insights generated.
Potential limitations of RWE include data heterogeneity, missing data, and confounding factors inherent in observational studies. Domino.ai addresses these by employing advanced analytical methods, such as causal inference models and propensity score matching, to mitigate bias and improve the interpretability of findings. The platform also provides transparency regarding data sources and their limitations to inform researchers' interpretations.
Domino.ai offers significant advantages in cost-effectiveness and time efficiency compared to traditional methods by enabling in silico experimentation and hypothesis generation, reducing the need for extensive wet-lab work and large-scale prospective studies. By leveraging existing RWE, it can rapidly identify promising drug candidates and optimize trial designs, potentially shortening development timelines and lowering overall research expenditures.
Yes, Domino.ai is designed for flexible integration with existing research infrastructure. It offers APIs and data connectors that allow seamless ingestion of proprietary datasets from pharmaceutical companies or academic institutions, enabling researchers to combine their internal data with Domino.ai's extensive RWE repository for a more comprehensive analytical approach.

Related Tools

Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Free
Trially AI
Trially AI
Drug Discovery & Research
Trially's HIPAA-compliant AI platform matches, engages, and enrolls patients into trials with high accuracy, built for physicians and research sites.
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.
Mendel.ai
Mendel.ai
Clinical Decision Support & Reference
Mendel.ai uses Neuro-Symbolic AI to sort patient cohorts from EHRs for clinical trial matching, accelerating research.
Contact for pricing
Haystack Enroll
Haystack Health
Drug Discovery & Research
Haystack Health is a clinical trial platform that utilizes AI and care navigation to connect health plan members and ACO patients with relevant clinical trials, aiming to expand treatment access and improve outcomes.
Custom quote
Dyania Health Clinical Trial Recruitment
Dyania Health
Drug Discovery & Research
Dyania Health's AI-powered software automates patient identification from EHRs for clinical trial recruitment, serving hospitals, health systems, and pharmaceutical companies.

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-08-23 | First Added: 2026-08-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.